BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
1160 results:

  • 1. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma.
    López JC; Ielpo B; Iglesias M; Pinilla FB; Sánchez-Velázquez P
    Langenbecks Arch Surg; 2024 Apr; 409(1):122. PubMed ID: 38607450
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
    Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
    Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    Di Carlo P; Serra N; Fasciana TMA; Giammanco A; D'Arpa F; Rea T; Napolitano MS; Lucchesi A; Cascio A; Sergi CM
    PLoS One; 2024; 19(2):e0294049. PubMed ID: 38381746
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A case report of cardia carcinoma: Underwent Heller myotomy for Achalasia.
    Wen LQ; Wei DW
    Medicine (Baltimore); 2024 Jan; 103(4):e36924. PubMed ID: 38277562
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study.
    Goess R; Jäger C; Perinel J; Pergolini I; Demir E; Safak O; Scheufele F; Schorn S; Muckenhuber A; Adham M; Novotny A; Ceyhan GO; Friess H; Demir IE
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38271272
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
    Yang Y; Yue C; Li Y; Piao Y
    Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inadequacy of the eighth edition of the American Joint Committee on cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant lesions in the pancreas: an analysis using the National cancer Database.
    Jung HS; Lee M; Han Y; Thomas AS; Yun WG; Cho YJ; Kluger MD; Jang JY; Kwon W
    HPB (Oxford); 2024 Mar; 26(3):400-409. PubMed ID: 38114399
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Contemporary Outcomes of Transduodenal Sphincteroplasty: the Importance of Surgical Quality.
    Walia S; Zaidi MY; McGuire S; Milam C; Fogel EL; Sherman S; Lehman G; Pitt HA; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Timsina L; Zyromski NJ
    J Gastrointest Surg; 2023 Dec; 27(12):2885-2892. PubMed ID: 38062321
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Increased plasma miR-370-3p expression in poor-outcome patients with pancreatic ductal adenocarcinoma.
    Harada T; Uemura K; Sumiyoshi T; Shintakuya R; Okada K; Hara T; Takahashi S; Hiyama E
    Pancreatology; 2023 Dec; 23(8):996-1002. PubMed ID: 37945497
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical impact of spacer placement surgery with expanded polytetrafluoroethylene sheet for particle therapy.
    Fujinaka R; Komatsu S; Terashima K; Demizu Y; Omiya S; Kido M; Toyama H; Tokumaru S; Okimoto T; Fukumoto T
    Radiat Oncol; 2023 Oct; 18(1):173. PubMed ID: 37875956
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
    Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
    J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Treatment Patterns and Outcomes in pancreatic cancer: A Comparative Analysis of Ontario and the USA.
    Saadat LV; Schofield E; Bai X; Curry M; Saskin R; Lipitz-Snyderman A; Soares KC; Kingham TP; Jarnagin WR; D'Angelica MI; Wright FC; Irish JC; Coburn NG; Wei AC
    Ann Surg Oncol; 2024 Jan; 31(1):58-65. PubMed ID: 37833463
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
    Valdera FA; O'Shea AE; Smolinsky TR; Carpenter EL; Adams AA; McCarthy PM; Tiwari A; Chick RC; Kemp-Bohan PM; Van Decar S; Thomas KK; Bader JO; Peoples GE; Clifton GT; Stojadinovic A; Nelson DW; Vreeland TJ
    J Surg Oncol; 2024 Feb; 129(2):244-253. PubMed ID: 37800378
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable pancreatic Ductal Adenocarcinomas.
    Miyata Y; Yonamine N; Fujinuma I; Tsunenari T; Takihata Y; Hakoda H; Nakazawa A; Iwasaki T; Einama T; Togashi J; Tsujimoto H; Ueno H; Beck Y; Kishi Y
    Ann Surg Oncol; 2023 Dec; 30(13):8621-8630. PubMed ID: 37658273
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Palliative radiotherapy in pancreatic cancer: a retrospective study of 100 cases and regional patterns of practice.
    Liu AKN; Lefresne S
    Ann Palliat Med; 2023 Sep; 12(5):891-899. PubMed ID: 37574574
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association between Rural Residence and Processes of Care in pancreatic cancer Treatment.
    Amin K; Khan H; Hearld LR; Chu DI; Prete V; Mehari KR; Heslin MJ; Fonseca AL
    J Gastrointest Surg; 2023 Oct; 27(10):2155-2165. PubMed ID: 37553515
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis.
    Schlick K; Gantschnigg A; Seymer A; Huemer F; Greil R; Weiss L
    Cancer Med; 2023 Aug; 12(16):16997-17004. PubMed ID: 37537780
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association between Metabolically Healthy Status and Risk of Gastrointestinal cancer.
    Cui H; Tian F; Chen Y; Ma X
    Cancer Res Treat; 2024 Jan; 56(1):238-246. PubMed ID: 37536710
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas.
    Oz O; Argon A; Kebat TA; Ozdemir O; Yakan S
    Indian J Pathol Microbiol; 2023; 66(3):533-539. PubMed ID: 37530334
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 58.